Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Williams

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Journal of Clinical and Experimental Hepatology|February 7, 2020
Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom CohortMunirah Alsaleh, Zoe Leftley, Thomas A Barbera, et al.
Biochimica Et Biophysica Acta|November 4, 2015
Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosisJason D Coombes, Steve S Choi, Marzena Swiderska-Syn, et al.
Frontiers in Immunology|June 15, 2017
Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B PatientsSandra Phillips, Sameer Mistry, Antonio Riva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.
Journal of Neuro-Oncology|December 3, 2003
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumorsJohn H Sampson, Gamal Akabani, Gary E Archer, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trialRafael Bañares, Frederik Nevens, Fin Stolze Larsen, et al.
Lancet (London, England)|December 20, 2016
New metrics for the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Richard Aspinall, et al.
Lancet (London, England)|March 14, 2021
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UKRoger Williams, Charles Alessi, Graeme Alexander, et al.
Lancet (London, England)|December 5, 2017
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Iain Armstrong, et al.
JCI Insight|November 22, 2019
Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosisJasmohan S Bajaj, Nita Salzman, Chathur Acharya, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Journal of Clinical and Experimental Hepatology|February 7, 2020
Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom CohortMunirah Alsaleh, Zoe Leftley, Thomas A Barbera, et al.
Biochimica Et Biophysica Acta|November 4, 2015
Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosisJason D Coombes, Steve S Choi, Marzena Swiderska-Syn, et al.
Frontiers in Immunology|June 15, 2017
Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B PatientsSandra Phillips, Sameer Mistry, Antonio Riva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.
Journal of Neuro-Oncology|December 3, 2003
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumorsJohn H Sampson, Gamal Akabani, Gary E Archer, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trialRafael Bañares, Frederik Nevens, Fin Stolze Larsen, et al.
Lancet (London, England)|December 20, 2016
New metrics for the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Richard Aspinall, et al.
Lancet (London, England)|March 14, 2021
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UKRoger Williams, Charles Alessi, Graeme Alexander, et al.
Lancet (London, England)|December 5, 2017
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Iain Armstrong, et al.
JCI Insight|November 22, 2019
Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosisJasmohan S Bajaj, Nita Salzman, Chathur Acharya, et al.
Pageof 22